Search Results - "Weinstock‐Guttman, B."

Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5‐year longitudinal study by Jakimovski, D., Gandhi, S., Paunkoski, I., Bergsland, N., Hagemeier, J., Ramasamy, D. P., Hojnacki, D., Kolb, C., Benedict, R. H. B., Weinstock‐Guttman, B., Zivadinov, R.

“…Background Cardiovascular diseases (CVDs) are more frequent in multiple sclerosis (MS) patients when compared to controls. In particular, CVDs are linked with…”
Get full text

Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow‐up by Murali, N., Browne, R. W., Fellows Maxwell, K., Bodziak, M. L., Jakimovski, D., Hagemeier, J., Bergsland, N., Weinstock‐Guttman, B., Zivadinov, R., Ramanathan, M.

“…Background and purpose Cholesterol is an important structural component of myelin and essential for brain homeostasis. Our objective was to investigate whether…”
Get full text

Hemostasis biomarkers in multiple sclerosis by Ziliotto, N., Bernardi, F., Jakimovski, D., Baroni, M., Marchetti, G., Bergsland, N., Ramasamy, D. P., Weinstock‐Guttman, B., Schweser, F., Zamboni, P., Ramanathan, M., Zivadinov, R.

“…Background and purpose The aim was to investigate the plasma levels of hemostasis components in multiple sclerosis (MS) and their association with clinical and…”
Get full text

Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study by Zivadinov, R., Hagemeier, J., Bergsland, N., Tavazzi, E., Weinstock‐Guttman, B.

“…Background and purpose Dimethyl fumarate (DMF) is an oral treatment for relapsing‐remitting multiple sclerosis (MS) with anti‐inflammatory and possible…”
Get full text

Infectious exposure, antibiotic use, and multiple sclerosis: A population‐based incident case‐control study by Abdollahpour, I., Nedjat, S., Mansournia, M. A., Eckert, S., Weinstock‐Guttman, B.

“…Background The existing reports regarding the potential role of infections as well as antibiotic use in multiple sclerosis (MS) etiology are inconclusive…”
Get full text

Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis by Ziliotto, N., Zivadinov, R., Baroni, M., Marchetti, G., Jakimovski, D., Bergsland, N., Ramasamy, D. P., Weinstock‐Guttman, B., Straudi, S., Manfredini, F., Ramanathan, M., Bernardi, F.

“…Background and purpose The involvement of protein C (PC) pathway components in multiple sclerosis (MS) has scarcely been explored. The aim was to investigate…”
Get full text

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire by Benedict, RHB, Duquin, JA, Jurgensen, S, Rudick, RA, Feitcher, J, Munschauer, FE, Panzara, MA, Weinstock-Guttman, B

“…Background Brief cognitive performance tests and self-report measures of neuropsychological symptoms have been proposed for screening purposes in multiple…”
Get full text

Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years by Zivadinov, R., Hojnacki, D., Bergsland, N., Kennedy, C., Hagemeier, J., Melia, R., Ramasamy, D. P., Durfee, J., Carl, E., Dwyer, M. G., Weinstock-Guttman, B.

“…Background and purpose The long‐term benefit of natalizumab on brain atrophy progression in multiple sclerosis (MS) patients is unknown. Our aim was to…”
Get full text

Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis by Benedict, R HB, Fishman, I, McClellan, M M, Bakshi, R, Weinstock-Guttman, B

“…Introduction: The Beck Depression Inventory-Fast Screen (BDI-FS) is a brief self-report inventory designed to evaluate depression in patients with medical…”
Get full text

Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients by Zivadinov, R., Bergsland, N., Cappellani, R., Hagemeier, J., Melia, R., Carl, E., Dwyer, M. G., Lincoff, N., Weinstock-Guttman, B., Ramanathan, M.

“…Background and purpose Visual impairments are frequent in multiple sclerosis (MS). Optic neuritis can directly reduce retinal nerve fiber layer (RNFL)…”
Get full text

Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis by Kardys, A., Weinstock-Guttman, B., Dillon, M., Masud, M. W., Weinstock, N., Mahfooz, N., Lang, J. K., Weinstock, A., Lincoff, N., Zivadinov, R., Ramanathan, M.

“…Background and purpose To evaluate the associations between retinal nerve fiber layer (RNFL) thickness and lipid profiles in multiple sclerosis (MS). Methods…”
Get full text

Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis by Yeh, E. Ann, Weinstock-Guttman, B.

“…This paper presents a summary of the current knowledge of the mechanism of action of fingolimod (FTY720; Gilenya®; Novartis Pharma Stein AG, Stein,…”
Get full text

Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity by Sternberg, Z, Weinstock-Guttman, B, Hojnacki, D, Zamboni, P, Zivadinov, R, Chadha, K, Lieberman, A, Kazim, L, Drake, A, Rocco, P, Grazioli, E, Munschauer, F

“…Objectives To compare serum levels of the receptor for advanced glycation end products (sRAGE) between multiple sclerosis (MS) patients and healthy control…”
Get full text

Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study by Bergsland, N, Ramasamy, D, Tavazzi, E, Hojnacki, D, Weinstock-Guttman, B, Zivadinov, R

“…Leptomeningeal inflammation is associated with the development of global cortical gray matter atrophy in multiple sclerosis. However, its association with…”
Get full text

Use of the multiple sclerosis Functional Composite to predict disability in relapsing MS by RUDICK, R. A, CUTTER, G, BAIER, M, FISHER, E, DOUGHERTY, D, WEINSTOCK-GUTTMAN, B, MASS, M. K, MILLER, D, SIMONIAN, N. A

“…To determine whether the MS Functional Composite (MSFC) can predict future disease progression in patients with relapsing remitting MS (RR-MS). The MSFC was…”
Get full text

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis by RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M

Get full text

Extended interval dosing of natalizumab in multiple sclerosis by Zhovtis Ryerson, L, Frohman, T C, Foley, J, Kister, I, Weinstock-Guttman, B, Tornatore, C, Pandey, K, Donnelly, S, Pawate, S, Bomprezzi, R, Smith, D, Kolb, C, Qureshi, S, Okuda, D, Kalina, J, Rimler, Z, Green, R, Monson, N, Hoyt, T, Bradshaw, M, Fallon, J, Chamot, E, Bucello, M, Beh, S, Cutter, G, Major, E, Herbert, J, Frohman, E M

“…BackgroundNatalizumab (NTZ), a monoclonal antibody to human α4β1/β7 integrin, is an effective therapy for multiple sclerosis (MS), albeit associated with…”
Get full text

Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis by Zivadinov, R, Ramasamy, D P, Hagemeier, J, Kolb, C, Bergsland, N, Schweser, F, Dwyer, M G, Weinstock-Guttman, B, Hojnacki, D

“…Leptomeningeal contrast enhancement is found in patients with multiple sclerosis, though reported rates have varied. The use of 3D-fluid-attenuated inversion…”
Get full text

Thalamic atrophy and cognition in multiple sclerosis by HOUTCHENS, M. K, BENEDICT, R. H. B, KILLIANY, R, SHARMA, J, JAISANI, Z, SINGH, B, WEINSTOCK-GUTTMAN, B, GUTTMANN, C. R. G, BAKSHI, R

“…Recent studies have indicated that brain atrophy is more closely associated with cognitive impairment in multiple sclerosis (MS) than are conventional MRI…”
Get full text

Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine by Ghione, E, Bergsland, N, Dwyer, M G, Hagemeier, J, Jakimovski, D, Paunkoski, I, Ramasamy, D P, Silva, D, Carl, E, Hojnacki, D, Kolb, C, Weinstock-Guttman, B, Zivadinov, R

“…The assessment of brain atrophy in a clinical routine is not performed routinely in multiple sclerosis. Our aim was to determine the feasibility of brain…”
Get full text